Expression of absent in melanoma 2 in the liver and correlation with the degrees of liver damage in patients with chronic hepatitis B

Xiuqing Pang,Xinhua Li,Zhishuo Mo,Zhiying Feng,Yuhang Pan,Ziying Lei,Xingrong Zheng,Zhiliang Gao,Dongying Xie
DOI: https://doi.org/10.3877/cma.j.issn.1674-1358.2015.03.007
2015-01-01
Abstract:Objective To investigate the expression of absent in melanoma 2 (AIM-2) in liver of patients with chronic hepatitis B, and to evaluate the correlation between the expression level of AIM-2 and the degree of liver damage. Methods AIM2 were detected in 73 liver specimens including 54 from common CHB patients, 19 from patients with acute-on-chronic liver failure (HBV-ACLF), and 20 from healthy controls by immunohistochemical staining. Semi-quantitative of the integral absorbance were conducted by the software Image-Pro-Plus 6.0. The correlation between the AIM-2 levels and the degree of liver damage were analyzed, respectively. Results AIM-2 expression was exclusive to the hepatic cellular cytoplasm in the liver tissue of patients with HBV. The median integral absorbance of AIM-2 in CHB patients was 4 996.88, which was signiifcantly higher than that in healthy controls of 2296.49 (Z=-3.028, P=0.002), but was less than that in HBV-ACLF patients with 19 772.48 (Z=-5.008, P<0.001). The integral absorbance of AIM-2 in CHB patients was also positive correlated with the score of histological activity index (HAI) in liver (r=0.707, P<0.0001). Conclusions AIM-2 rarely expressed in healthy liver, but signiifcantly up-regulation were found in patients with chronic hepatitis B especially in patients with acute-on-chronic liver failure, indicating that AIM-2 may contribute to the pathogeneses of liver damage in chronic hepatitis B and liver failure.
What problem does this paper attempt to address?